FCA Examining Claims Share Price of Woodford-held Burford Capital was Illegally Manipulated (Independent.co.uk)
The Financial Conduct Authority (FCA) is looking into claims that the share price of Burford Capital – the second-largest holding in Neil Woodford’s suspended fund – was illegally manipulated around the time of an attack by US hedge fund Muddy Waters. Burford, which provides funding for legal action and takes a cut of the resulting settlements, saw its share value nosedive over the past week after Muddy Waters took a short position on the stock, betting that its value would fall, before publishing a damning report on the company’s financial health.
U.S. Charges RBC Analyst with Insider Trading Ahead of Client’s Merger (Reuters)
NEW YORK (Reuters) – U.S. prosecutors on Monday criminally charged a junior analyst at RBC Capital Markets with insider trading, saying he bought options in a digital printing company after learning it was in talks to be acquired by an RBC client. Bill Tsai, 23, who graduated last year from New York University’s Stern School of Business, was charged with one count of securities fraud, carrying a maximum 20-year prison term.
A Director at Arrow Financial Corp (NASDAQ: AROW) is Selling Shares (Analyst Ratings)
Today, a Director at Arrow Financial Corp (AROW), Gary Dake, sold shares of AROW for $113.3K. In addition to Gary Dake, 2 other AROW executives reported Sell trades in the last month. Based on Arrow Financial Corp’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $34.12 million and quarterly net profit of $8.93 million. In comparison, last year the company earned revenue of $31.5 million and had a net profit of $9.73 million. AROW’s market cap is $475.4M and the company has a P/E ratio of 13.32. Currently, Arrow Financial Corp has an average volume of 8,439.
Guru Focus (Guru Focus)
Executive vice president & CFO of Chemed Corp, David Patrick Williams, sold 17,979 shares of CHE on 08/12/2019 at an average price of $430.8 a share. The total sale was $7.7 million. Chemed Corp through its subsidiaries, provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers and also plumbing and drain cleaning services. Chemed Corp has a market cap of $6.86 billion; its shares were traded at around $430.55 with a P/E ratio of 35.60 and P/S ratio of 3.88. The dividend yield of Chemed Corp stocks is 0.28%.
The President & CEO of TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) is Buying Shares (Analyst Ratings)
Today, the President & CEO of TRACON Pharmaceuticals, Inc. (TCON), Charles Theuer, bought shares of TCON for $22.5K. This recent transaction increases Charles Theuer’s holding in the company by 40.46% to a total of $78.1K. Currently, TRACON Pharmaceuticals, Inc. has an average volume of 83.11K. Company insider trades are published daily on the SEC (Securities and Exchange Commission).